Finance

Beta
Lists
300529:SHE
Jafron Biomedical Co Ltd
CNÂ¥17.22
-0.17%
(-0.030) 1D
Jun 5, 3:04:07 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300529...
Open
CNÂ¥17.25
High
CNÂ¥17.50
Low
CNÂ¥17.08
Mkt. cap
13.75B
Avg. vol.
6.43M
Volume
5.24M
Dividend
3.02%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 1, 2026
P/E ratio
24.03
52-wk high
CNÂ¥24.98
52-wk low
CNÂ¥17.08
EPS
CNÂ¥0.72
Shares outstanding
798.61M
No. of employees
2K
Open
CNÂ¥17.25
High
CNÂ¥17.50
Low
CNÂ¥17.08
Mkt. cap
13.75B
Avg. vol.
6.43M
Volume
5.24M
Dividend
3.02%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 1, 2026
P/E ratio
24.03
52-wk high
CNÂ¥24.98
52-wk low
CNÂ¥17.08
EPS
CNÂ¥0.72
Shares outstanding
798.61M
No. of employees
2K
News stories
From sources across the web
About Jafron Biomedical Co Ltd
CEO-
Employees2.3K
FoundedDec 19, 1989
Headquarters-
SectorMedical device
Websitejafron.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
586.58M
421.61M
455.80M
560.62M
Cost of goods sold
129.59M
82.44M
122.83M
127.54M
Cost of revenue
129.59M
82.44M
122.83M
127.54M
Research and development expenses
44.47M
49.57M
51.42M
45.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
172.58M
172.41M
135.77M
115.42M
Operating expense
226.06M
226.42M
197.92M
166.90M
Total operating expenses
355.65M
308.86M
320.75M
294.44M
Operating income
230.93M
112.74M
135.05M
266.18M
Other non operating income
1.79M
-2.81M
3.02M
-1.18M
EBT including unusual items
236.77M
90.15M
108.07M
260.01M
EBT excluding unusual items
231.21M
100.80M
171.31M
258.91M
Income tax expense
36.28M
26.96M
28.26M
39.37M
Effective tax rate
15.32%
29.91%
26.15%
15.14%
Other operating expenses
9.09M
7.07M
8.52M
4.18M
Net income
200.94M
63.51M
79.59M
220.51M
Net profit margin
34.26%
15.06%
17.46%
39.33%
Earnings per share
-
-
-
-
Interest and investment income
11.42M
3.94M
48.69M
6.26M
Interest expense
-12.59M
-13.41M
-13.28M
-12.35M
Net interest expenses
-1.17M
-9.47M
35.41M
-6.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
260.81M
143.16M
164.34M
295.47M
Gain or loss from assets sale
1.41M
-1.41M
79.85K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more